Roche Holding AG - Total Other Income Expense Net
Roche Holding AG's Fiscal Year is From January To December - All Figures are in CHF, Billions.
The item "Total-Other-Income-Expense-Net" stands at -3.10 Billion Swiss Francs for the trailing twelve months (TTM) period ending 06/30/2026.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 1.04 Billion Swiss Francs compared to the value the year prior.
The 1 year change is 1.04 Billion Swiss Francs.
The 3 year change is 2.28 Billion Swiss Francs.
The 5 year change is -3.66 Billion Swiss Francs.
The 10 year change is -0.388 Billion Swiss Francs.
The Serie's change in Swiss Francs from it's minimum value, on 12/31/2024, to it's latest available value, on 06/30/2026, is +3.97 Billion.
The Serie's change in Swiss Francs from it's maximum value, on 06/30/2021, to it's latest available value, on 06/30/2026, is -3.66 Billion.
Total Other Income Expense Net for Related Companies:
| Logo | Name | Market Cap (USD) |
|---|---|---|
 | Eli Lilly and Company - Total Other Income Expense Net | 905,699,262,464.00 |
 | Johnson & Johnson - Total Other Income Expense Net | 486,508,953,600.00 |
 | AbbVie Inc - Total Other Income Expense Net | 399,570,305,024.00 |
 | AstraZeneca PLC - Total Other Income Expense Net | 280,205,508,085.11 |
 | Novartis AG - Total Other Income Expense Net | 255,096,620,580.91 |